| 09.00-09.15 | Introduction, issues of the Austox programme
Dr John Lewis |
| 09.15-09.55 | Review of 2003 qualitative cycle
Peter Bowron |
| 09.55-10.30 | Review of 2003 quantitative cycle
Peter Bowron
|
| 10.30-11.00 | MORNING TEA
|
| 11.00-11.30 | The UKNEQAS experience
Dr John Williams |
| 11.30-12.10 | Issues arising from ROSITA and roadside drug testing
Dr Alain Verstraete |
| 12.10-12.30 | European workplace testing guidelines
Anya Pierce
|
| 12.30-13.30 | LUNCH
|
| 13.30-14.00 | Accreditation of labs in Canada
Dr. Albert Fraser |
| 14.00-14.45 | Accreditation of laboratories in Australia and interpretation of AS/NZ 4308
Prof. Olaf Drummer |
| 14.45-15.30 | Clinical Toxicology in the UK
Dr Steve George
|
| 15.30-16.00 | AFTERNOON TEA
|
| 16.00-16.30 | Uncertainty Measurement
Group discussion |
| 16.30-17.00 | CEDIA Buprenorphine assay
Dr Michael Boettcher |
| 17.00-17.15 | Summation of Workshop
Dr John Lewis |
| 16.30-17.00 | Committee meeting
Austox Committee |
